Inventor
WHITLOCK GAVIN ALISTAIR
GB22 patents
⚠️ This page may combine multiple inventors who share the name “WHITLOCK GAVIN ALISTAIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
8 patentsUS6090852AJul 18, 2000
Substituted alpha-aminosulphonyl-acetohydroxamic acids as therapeutic agents
PFIZER31 citations92
US7378436B2May 27, 2008
Compounds
PFIZER50 citations90
US9518052B2Dec 13, 2016
Pyrazolopyridines and pyrazolopyrimidines
PFIZER8 citations83
US10022376B2Jul 17, 2018
Pyrazolopyridines and pyrazolopyrimidines
PFIZER3 citations72
US7122683B2Oct 17, 2006
Amides useful as monoamine re-uptake inhibitors
PFIZER4 citations61
US6831088B2Dec 14, 2004
3-heterocyclypropanohydroxamic acid PCP inhibitors
PFIZER2 citations59
US6716861B2Apr 6, 2004
3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors
PFIZER2 citations59
US7214694B2May 8, 2007
3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors
PFIZER1 citations49
MISSION THERAPEUTICS LTD
7 patentsUS9926307B2Mar 27, 2018
Compounds
MISSION THERAPEUTICS LTD14 citations92
US10392380B2Aug 27, 2019
Compounds
MISSION THERAPEUTICS LTD6 citations83
US11472798B2Oct 18, 2022
Compounds
MISSION THERAPEUTICS LTD1 citations72
US10774078B2Sep 15, 2020
Compounds
MISSION THERAPEUTICS LTD2 citations72
US10640498B2May 5, 2020
Compounds
MISSION THERAPEUTICS LTD6 citations71
US11993595B2May 28, 2024
Compounds
MISSION THERAPEUTICS LTD0 citations62
US10683269B2Jun 16, 2020
2-cyanoisoindoline derivatives for treating cancer
MISSION THERAPEUTICS LTD1 citations60